Ameliorating Effect of Bifidobacterium breve CM02‐09T on High‐Fat Diet‐Induced Nonalcoholic Fatty Liver Disease in Mice
The FASEB Journal · 31.08.2025 · 39 (16)
DOI: 10.1096/fj.202501250rr ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 20.08.2025. Verfasst von Yu Tian und 13 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Sciences, Northwest University, Xi'an, China. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Diet, High-Fat, Probiotics, Bifidobacterium breve. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Natural Science Foundation of China-Guangdong Joint Fund.
Abstract (Originalsprache)
Evidences have demonstrated that the regulation of gut microbiota by probiotics can be utilized to prevent nonalcoholic fatty liver disease (NAFLD); Bifidobacterium was widely used as a potential therapeutic alternative for metabolic diseases. In this study, the probiotic functions of Bifidobacterium breve CM02‐09T and its effects on NAFLD were investigated through genome annotation and high‐fat diet (HFD)‐induced mouse model. The genome of B. breve CM02‐09T consists of a single circular chromosome of 2 372 890 bp. Eighteen male C57BL/6J mice were fed a normal chow diet (NCD), a high‐fat diet, and a high‐fat diet (HFD) with B. breve CM02‐09T separately for 12 weeks. Histopathology, lipid content, biochemical markers in the liver and blood, and metagenomics were assessed and compared. Our results indicate that supplementation with B. breve CM02‐09T alleviated liver damage, reduced fat accumulation in the liver and epididymal adipose tissue, decreased TNF‐α concentration, and improved NAFLD activity scores. Metagenomic analysis revealed that administration of B. breve CM02‐09T promoted a decreased Firmicutes/Bacteroidetes ratio (F/B), an increase in beneficial bacteria, and enhanced lipid metabolism functions. Correlation analysis between the differential species and NAFLD‐related indicators suggested that the anti‐NAFLD effect of B. breve CM02‐09T is related to the gut microbiota. Therefore, B. breve CM02‐09T attenuates NAFLD by modulating the gut microbiota and could be used as an alternative therapeutic strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Life Sciences, Northwest University, Xi'an, China.
- BGI Research, Shenzhen, China.
- College of Life Sciences, University of Chinese Academy of Sciences, Beijing, China.
- School of Biological Sciences, Monash University, Melbourne, Victoria, Australia.
- School of Basic Medicine, Qingdao Medical College, Qingdao University, Qingdao, China.
- BGI Precision Nutrition, Shenzhen, China.
ORCID-Profile: Yu Tian
Förderung
- National Natural Science Foundation of China-Guangdong Joint Fund
Zitieren
APA
Tian, Y., Xu, Q., Wu, Z., Wang, H., Hu, X., He, N., Li, H., Liu, B., Zhong, Y., Zhang, H., Wang, M., Xiao, L., Li, S., & Zou, Y. (2025). Ameliorating Effect of Bifidobacterium breve CM02‐09T on High‐Fat Diet‐Induced Nonalcoholic Fatty Liver Disease in Mice. The FASEB Journal, 39(16). https://doi.org/10.1096/fj.202501250rr
Vancouver
Tian Y, Xu Q, Wu Z, Wang H, Hu X, He N, et al. Ameliorating Effect of Bifidobacterium breve CM02‐09T on High‐Fat Diet‐Induced Nonalcoholic Fatty Liver Disease in Mice. The FASEB Journal. 2025;39(16). doi:10.1096/fj.202501250rr
BibTeX
@article{Tian2025,
author = {Tian, Yu and Xu, Qianyue and Wu, Zhinan and Wang, Haoyu and Hu, Xiangtao and He, Ningning and Li, Hui and Liu, Bei and Zhong, Yiyi and Zhang, Haifeng and Wang, Mengmeng and Xiao, Liang and Li, Shangyong and Zou, Yuanqiang},
title = {Ameliorating Effect of Bifidobacterium breve CM02‐09T on High‐Fat Diet‐Induced Nonalcoholic Fatty Liver Disease in Mice},
journal = {The FASEB Journal},
year = {2025},
volume = {39},
number = {16},
doi = {10.1096/fj.202501250rr}
}
EUVIMED